Further studies on 2-arylacetamide pyridazin-3(2H)-ones: Design, synthesis and evaluation of 4,6-disubstituted analogs as formyl peptide receptors (FPRs) agonists-Reference-Cited by-同舟云学术

Further studies on 2-arylacetamide pyridazin-3(2H)-ones: Design, synthesis and evaluation of 4,6-disubstituted analogs as formyl peptide receptors (FPRs) agonists

Published:2013-06 Issue: Volume:64 Page:512-528
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Giovannoni Maria Paola,Schepetkin Igor A.,Cilibrizzi Agostino,Crocetti Letizia,Khlebnikov Andrei I.,Dahlgren Claes,Graziano Alessia,Dal Piaz Vittorio,Kirpotina Liliya N.,Zerbinati Serena,Vergelli Claudia,Quinn Mark T.

Funder

National Institutes of Health

Montana State University Agricultural Experimental Station

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference57 articles.

1. Formyl-peptide receptors revisited;Le;Trends Immunol.,2002

2. Formyl peptide receptors: a promiscuous subfamily of G protein-coupled receptors controlling immune responses;Migeotte;Cytok. Growth Factor Rev.,2006

3. International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family;Ye;Pharmacol. Rev.,2009

4. Multiple domains of the N-formyl peptide receptor are required for high-affinity ligand binding. Construction and analysis of chimeric N-formyl peptide receptors;Quehenberger;J. Biol. Chem.,1993

5. Identification and characterization of an endogenous chemotactic ligand specific for FPRL2;Migeotte;J. Exp. Med.,2005

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis, COX-2 inhibition, anti-inflammatory activity, molecular docking, and histopathological studies of new pyridazine derivatives;Bioorganic Chemistry;2024-09

2. The formyl peptide receptors FPR1 and FPR2 as targets for inflammatory disorders: recent advances in the development of small-molecule agonists;European Journal of Medicinal Chemistry;2024-02

3. Unveiling the ESR1 Conformational Stability and Screening Potent Inhibitors for Breast Cancer Treatment;Medicinal Chemistry;2023-10-27

4. Exploring Three Avenues: Chemo- and Regioselective Transformations of 1,2,4-Triketone Analogs into Pyrazoles and Pyridazinones;International Journal of Molecular Sciences;2023-09-18

5. Optimization of 4‐amino‐pyridazin‐3(2H)‐one as a valid core scaffold for FABP4 inhibitors;Archiv der Pharmazie;2023-07-30